| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/27/2002 | EP1189917A1 48 human secreted proteins |
| 03/27/2002 | EP1189901A1 Oxazaheterocycles as protease inhibitors |
| 03/27/2002 | EP1189663A2 Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders |
| 03/27/2002 | EP1189631A1 Neurodegenerative disorder related gene |
| 03/27/2002 | EP1189630A1 A method of prophylaxis and treatment and agents useful for same |
| 03/27/2002 | EP1189629A2 Methods and reagents for treating glucose metabolic disorders |
| 03/27/2002 | EP1189628A1 Combination of tumor necrosis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
| 03/27/2002 | EP1189627A1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
| 03/27/2002 | EP1189626A1 Method for preventing tumoral growth |
| 03/27/2002 | EP1189625A1 Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c) |
| 03/27/2002 | EP1189624A1 Hla binding peptides and their uses |
| 03/27/2002 | EP1189623A2 Method and composition for inhibiting cardiovascular cell proliferation |
| 03/27/2002 | EP1189622A2 Anionic polymers as toxin binders and antibacterial agents |
| 03/27/2002 | EP1189615A2 Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines |
| 03/27/2002 | EP1189611A1 Cancer therapy |
| 03/27/2002 | EP1189600A1 Grf-containing lyophilized pharmaceutical compositions |
| 03/27/2002 | EP1077068B1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 03/27/2002 | EP1009418B1 Robinia pseudoacacia lectin and its uses |
| 03/27/2002 | EP1007534A4 Bh3 interacting domain death agonist |
| 03/27/2002 | EP0957931B1 Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant |
| 03/27/2002 | EP0870018B1 Antitumour vector constructs and methods |
| 03/27/2002 | EP0869809B1 Oxidized glutathione as cytokine and hemopoietic factor endogenous production enhancer |
| 03/27/2002 | EP0837673B1 Polymeric lamellar substrate particles for drug delivery |
| 03/27/2002 | EP0831906B1 Treatment of t cell mediated autoimmune disorders |
| 03/27/2002 | EP0773999B1 Or-1 an orphan receptor belonging to the nuclear receptor family |
| 03/27/2002 | EP0730608B1 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
| 03/27/2002 | EP0730470B1 Improved interferon polymer conjugates |
| 03/27/2002 | EP0621875B1 Fibrinogen binding protein |
| 03/27/2002 | EP0610336B1 Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 03/27/2002 | EP0608341B1 Enzyme-orthokeratology |
| 03/27/2002 | CN1342264A Heart abnormalities in vascular endothelial growth factor B(VEGF-B) deficient animals and methods relating to these heart abnormalities |
| 03/27/2002 | CN1342206A Adenoviruses deleted in IVa2, 100K and/or preterminal protein sequences |
| 03/27/2002 | CN1342205A Histidine protein-phosphatase |
| 03/27/2002 | CN1342202A Soluble receptor BR43X2 and methods for using them for therapy |
| 03/27/2002 | CN1342167A Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 03/27/2002 | CN1342166A GLP-1 analogues |
| 03/27/2002 | CN1342165A Neurotrophic growth factor |
| 03/27/2002 | CN1342164A Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators |
| 03/27/2002 | CN1342096A Synergistic tumorcidal response induced by histamine |
| 03/27/2002 | CN1342088A Polypeptide comprising amino acid of AN N-terminal choline binding protein truncate, vaccine derived therefrom and uses thereof |
| 03/27/2002 | CN1342087A Preparations stabilized over long time |
| 03/27/2002 | CN1342086A Functional oral preparations |
| 03/27/2002 | CN1342085A Inhibition of differentiation of cytotoxic T-cells by p-selecting ligand (PSGL) antagonists |
| 03/27/2002 | CN1342084A Therapeutic compositions containing glutathione analogs |
| 03/27/2002 | CN1342083A Uses of 1-amino-3-(N,N-dimethylamino)propylidene-1,1-bisphosphonic acid |
| 03/27/2002 | CN1342079A Treatment and prevention of reactive oxygen metablite-mediated cellular damage |
| 03/27/2002 | CN1342077A Inhibition of formation of vascular hyperpermeability |
| 03/27/2002 | CN1342076A Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors |
| 03/27/2002 | CN1342066A Non-invasive vaccination through skin |
| 03/27/2002 | CN1341753A Method for diagnosing and curing dentinogenesis imperfacta type II by using dentin salivary phosphoprotein gene and its coded product |
| 03/27/2002 | CN1341747A A novel polypeptide-human protein 8.91 with delta-amino-gamma-ketovaleric dehydratase characteristic sequence fragment and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341746A A novel polypeptide-human endopolypeptidase 11.66 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341745A A novel polypeptide-human ATP dependent serine proteolytic enzyme 9.57 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341744A A novel polypeptide-human ATP dependent membrane-associated zinc protein 14.63 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341743A A novel polypeptide-signal peptidase 12.87 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341742A A novel polypeptide-amylase 15.95 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341741A A novel polypeptide-human phosphatidase 9.24 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341740A A novel polypeptide-adenosine triphosphate dependent ribonucleic acid uncoiling enzyme 52.80 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341739A A novel polypeptide-human protein tyrosine phosphatase 9.02 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341738A A novel polypeptide-phosphodiesterase 30.58 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341737A A novel polypeptide-human haploid sperm cell specific nucleoprotein kinase 49.94 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341736A A novel polypeptide-human phosphorylcholine/ethanolamine transferase 9.35 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341735A A novel polypeptide-phosphoenolpyruvate dependent saccharophophotransferase 9.46 and polynucleotide for coidng said polypeptide |
| 03/27/2002 | CN1341734A A novel polypeptide-human dynein receptor similarity kinase 10.56 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341733A A novel polypeptide-glutathion S-transferase zeta group (GST-zeta) 11.66 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341732A A novel polypeptide-human alcohol dehydrogenase 46.53 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341731A A novel polypeptide-human short chain dehydrogenase 8.8 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341730A A novel polypeptide-human ribonucleotide reductase 8.91 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341729A A novel polypeptide-human 6-pyruvoly tetrahydro (bio) pterin synthetase (PTPS) 11.66 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341728A A novel polypeptide-3-tiglyl CoA carboxylase 43.56 and polynucleotide for coidng said polypeptide |
| 03/27/2002 | CN1341727A A novel polypeptide-methionyl tRNA conjugated enzyme 35.09 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341726A A novel polypeptide-asparagine tRNA synthetase 27.50 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341725A A novel polypeptide-human threonyl-tRNA synthetase 48.73 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341724A A novel polypeptide-phosphatidylserine decarboxylating enzyme 42.68 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341723A A novel polypeptide-ubiquitin-conjugated enzyme 10.56 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341722A A novel polypeptide-human RNA polymerase III subunit 21.45 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341721A A novel polypeptide-human reverse transcriptive enzyme 9.13 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341720A A novel polypeptide-polynucleotide phosphorylase 74.25 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341719A A novel polypeptide-arginyl tRNA synthetase 15.84 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341718A A novel polypeptide-ubiquitin-conjugated enzyme 21.01 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341662A Scorpion pain-stopping anti-tumor Val-Arg-Gly peptide and its preparation method |
| 03/27/2002 | CN1341658A A novel polypeptide-human cyclin-E conjugated protein (Ceb1) 113-70.07 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341652A A novel polypeptide-human auditory injury related protein 38.39 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341644A A novel polypeptide-human heterogeneous nuclear-nucleoprotein 32.01 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341593A Proteinase inhibitor |
| 03/27/2002 | CN1341592A Proteinase inhibitor |
| 03/27/2002 | CN1341590A Proteinase inhibitor |
| 03/27/2002 | CN1081672C Fungicdal methods and compositions for killing yeast and sporular microorganisms |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362341 Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 03/26/2002 | US6362324 Used as target for diagnosis and treatment in aminopeptidase-related disorders such as aging, cancers, cataracts, cystic fibrosis and leukemias; used in drug-screening to identify agonists, antagonists |
| 03/26/2002 | US6362319 Glial cell line-derived neurotrophic factor |
| 03/26/2002 | US6362318 Protein called EPIL/placentin, process for the preparation of this protein and pharmaceutical composition containing such, DNA coding for said protein |
| 03/26/2002 | US6362308 Solubility in methylene chloride |
| 03/26/2002 | US6362204 Controlling immunology; antiinflammatory agents |
| 03/26/2002 | US6362194 Method and simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
| 03/26/2002 | US6362167 Method of blocking free radical processes which result in mediated pathology without deleterious pro-oxidant side reactions |
| 03/26/2002 | US6362165 Hydroxyphenyl derivatives with HIV integrase inhibitory properties |
| 03/26/2002 | US6362164 Combination of a somatostatin analogue and a rapamycin |
| 03/26/2002 | US6362163 Administering polypeptide |